These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 26993770)
1. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression. Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770 [TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2). Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. Zhou M; Liu Z; Zhao Y; Ding Y; Liu H; Xi Y; Xiong W; Li G; Lu J; Fodstad O; Riker AI; Tan M J Biol Chem; 2010 Jul; 285(28):21496-507. PubMed ID: 20460378 [TBL] [Abstract][Full Text] [Related]
5. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3. Ao X; Nie P; Wu B; Xu W; Zhang T; Wang S; Chang H; Zou Z Cell Death Dis; 2016 Nov; 7(11):e2463. PubMed ID: 27831559 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and biological significance of microRNA-127 expression in human breast cancer. Wang S; Li H; Wang J; Wang D; Yao A; Li Q Dis Markers; 2014; 2014():401986. PubMed ID: 25477702 [TBL] [Abstract][Full Text] [Related]
7. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis. Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma. Huang Y; Chen G; Wang Y; He R; Du J; Jiao X; Tai Q Biochem Biophys Res Commun; 2018 Sep; 503(2):1035-1041. PubMed ID: 29935185 [TBL] [Abstract][Full Text] [Related]
9. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808 [TBL] [Abstract][Full Text] [Related]
10. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells. Wu H; Wang G; Wang Z; An S; Ye P; Luo S FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells. Shi Y; Gong W; Lu L; Wang Y; Ren J Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305 [TBL] [Abstract][Full Text] [Related]
14. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel. Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer. Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Mei M; Ren Y; Zhou X; Yuan XB; Han L; Wang GX; Jia Z; Pu PY; Kang CS; Yao Z Technol Cancer Res Treat; 2010 Feb; 9(1):77-86. PubMed ID: 20082533 [TBL] [Abstract][Full Text] [Related]
17. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1. Gan CZ; Li G; Luo QS; Li HM IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895 [TBL] [Abstract][Full Text] [Related]
18. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer. Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318 [TBL] [Abstract][Full Text] [Related]
20. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer. Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]